News | November 27, 2022
LPU organizes conference on welfare of global community
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
The company sees the business reaching $100mn
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
Lupin is the 6th largest company in the Indian Pharmaceutical Market
Subscribe To Our Newsletter & Stay Updated
